Brind.

Renaissance Technologies Increases Stake in Lantern Pharma Inc.

1 report, 1 independent Updated Oct 8
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

On October 8, 2026, Renaissance Technologies increased its stake in Lantern Pharma Inc. Following this institutional activity, Lantern Pharma shares rose 1.4% during trading on Tuesday, reaching a high of $1.07. The stock traded at $0.9537 at the close of mid-day trading.

From tickerreport.com

Why it matters

Some supportBrind's analysis of the reports

The increase in institutional holdings by Renaissance Technologies occurred while Lantern Pharma's stock maintained a consensus

From tickerreport.com

Who's involved

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Renaissance Technologies might see changes in capital gains from this portfolio investment.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped